Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sascha Kießlich"'
Autor:
Marie-Angélique Sène, Sascha Kiesslich, Haig Djambazian, Jiannis Ragoussis, Yu Xia, Amine A. Kamen
Publikováno v:
npj Vaccines, Vol 6, Iss 1, Pp 1-10 (2021)
Abstract The Vero cell line is the most used continuous cell line for viral vaccine manufacturing with more than 40 years of accumulated experience in the vaccine industry. Additionally, the Vero cell line has shown a high affinity for infection by M
Externí odkaz:
https://doaj.org/article/7132a21470654cf7a9cefa5d2162ab40
Publikováno v:
MethodsX, Vol 7, Iss , Pp 100806- (2020)
The recombinant Vesicular Stomatitis Virus (rVSV) is an emerging platform for viral vector-based vaccines. Promising results have been reported in clinical trials for the rVSV-ZEBOV vaccine for Ebola virus disease prevention. In this study, we descri
Externí odkaz:
https://doaj.org/article/0eb9816a8f8c48b5b0a3ef7a4673bfdc
Autor:
Julia Puppin Chaves Fulber, Omar Farnós, Sascha Kiesslich, Zeyu Yang, Shantoshini Dash, Leonardo Susta, Sarah K. Wootton, Amine A. Kamen
Publikováno v:
Vaccines, Vol 9, Iss 11, p 1335 (2021)
The ongoing COVID-19 pandemic drew global attention to infectious diseases, attracting numerous resources for development of pandemic preparedness plans and vaccine platforms—technologies with robust manufacturing processes that can quickly be pivo
Externí odkaz:
https://doaj.org/article/b7aba1817a4c4c60b48596beb30861ff
Autor:
Jannie Perdersen, Parminder S. Chahal, Stéphane Lanthier, Gary P. Kobinger, Sascha Kiesslich, Hiva Azizi, Jean-François Gélinas, Amine Kamen, Sven Ansorge, Rénald Gilbert
Publikováno v:
Vaccine. 37:6624-6632
Ebola virus disease is an urgent international priority. Promising results for several vaccine candidates have been reported in non-human primate studies and clinical trials with the most promising being the rVSV-ZEBOV vaccine. In this study, we soug
The Vero cell line is the most used continuous cell line in viral vaccine manufacturing. This adherent cell culture platform requires the use of surfaces to support cell growth, typically roller bottles or microcarriers. We have recently compared the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9140e4455297eacf054ec8970828d074
https://doi.org/10.22541/au.161044033.35250019/v1
https://doi.org/10.22541/au.161044033.35250019/v1
Autor:
Amine Kamen, Gary P. Kobinger, Anahita Bakhshizadeh Gashti, Mathias Mangion, Hiva Azizi, Sascha Kiesslich, Rénald Gilbert, Parminder S. Chahal, Jean-François Gélinas, Nasha Nassoury, Bruno Gaillet, Alain Garnier
Publikováno v:
Vaccine. 38(50)
Acquired Immune Deficiency Syndrome (AIDS) in humans is a result of the destruction of the immune system caused by Human Immunodeficiency Virus (HIV) infection. This serious epidemic is still progressing world-wide. Despite advances in treatment, a s
Autor:
Lars Rehmann, Kai Gao, Erin Johnson, Garret Munch, Tahereh Sarchami, Wojciech Kujawski, Sascha Kießlich
Publikováno v:
Journal of Membrane Science. 535:79-88
Batch-wise butanol removal using vacuum pervaporation (VPV) was investigated to assess its technical feasibility for future integration with a continuous PBE (1,3-propanediol-butanol-ethanol) fermentation process using glycerol as feedstock. Two comm
Publikováno v:
Journal of biotechnology. 310
Ebola virus disease outbreaks have repeatedly occurred on the African continent over the last decades, with more serious outbreaks in recent years. Being highly transmissible and associated to high fatality rates, it constitutes a serious threat to p
Autor:
Amine Kamen, Sascha Kiesslich
Publikováno v:
Biotechnology Advances
The Vero cell line is considered the most used continuous cell line for the production of viral vectors and vaccines. Historically, it is the first cell line that was approved by the WHO for the production of human vaccines. Comprehensive experimenta
Publikováno v:
World journal of microbiologybiotechnology. 32(6)
Economic realities for the rising industrial biofuel production have changed substantially during the low oil price period starting in the mid 2010's. Increased competition requires the sector to increase productivity through the reduction of low-val